CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Allergan, Inc. v. Revance Therapeutics, Inc.

1:21-cv-01411

Overview

Case Number 1:21-cv-01411
Filing Date 2021-10-01
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Movant

BioSentinel, Inc. Operating Company

Represented By

3 Attorneys Listed

Robert D. Fish

Email: rfish@fishiplaw.com

Megan C. Haney

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, McLaughlin & Hall, P.A., DE

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Defendant

PCI San Diego, Inc. Operating Company

Represented By

19 Attorneys Listed

Andrew Solomon

Email: asolomon@cahill.com

Peter J. Armenio

Email: parmenio@cahill.com

Deirdre M. Wells

Email: dwells@sternekessler.com

Daniel G. Mackrides

Young Conaway Stargatt & Taylor LLP

Tel: +1 (302) 571-6647

1000 North King Street, Wilmington, DE 19801

Byron L. Pickard

Email: bpickard@sternekessler.com

Tyler C. Liu

Email: tliu@sternekessler.com

Nirav N. Desai

Email: ndesai@sternekessler.com

Marsha Rose Gillentine

Email: mgillentine@sternekessler.com

Louis P. Panzica , Jr.

Email: lpanzica@sternekessler.com

Christopher M. Gallo

Email: cgallo@sternekessler.com

Adil B. Moghal

Email: amoghal@sternekessler.com

Sasha S. Rao

Email: SRao@sternekessler.com

Anna G. Phillips

Email: aphillips@sternekessler.com

Ryan E. Conkin

Email: rconkin@sternekessler.com

Dennies Varughese

Email: dvarughese@sternekessler.com

Adam C. LaRock

Email: alarock@sternekessler.com

Samantha G. Wilson

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-5018

Rodney Square, 1000 North King Street

Anne Shea Gaza

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6727

Rodney Square, 1000 North King Street

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Revance Therapeutics, Inc. Operating Company

Represented By

18 Attorneys Listed

Andrew Solomon

Email: asolomon@cahill.com

Peter J. Armenio

Email: parmenio@cahill.com

Deirdre M. Wells

Email: dwells@sternekessler.com

Daniel G. Mackrides

Young Conaway Stargatt & Taylor LLP

Tel: +1 (302) 571-6647

1000 North King Street, Wilmington, DE 19801

Byron L. Pickard

Email: bpickard@sternekessler.com

Tyler C. Liu

Email: tliu@sternekessler.com

Nirav N. Desai

Email: ndesai@sternekessler.com

Marsha Rose Gillentine

Email: mgillentine@sternekessler.com

Louis P. Panzica , Jr.

Email: lpanzica@sternekessler.com

Christopher M. Gallo

Email: cgallo@sternekessler.com

Adil B. Moghal

Email: amoghal@sternekessler.com

Sasha S. Rao

Email: SRao@sternekessler.com

Anna G. Phillips

Email: aphillips@sternekessler.com

Ryan E. Conkin

Email: rconkin@sternekessler.com

Dennies Varughese

Email: dvarughese@sternekessler.com

Adam C. LaRock

Email: alarock@sternekessler.com

Samantha G. Wilson

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-5018

Rodney Square, 1000 North King Street

Anne Shea Gaza

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6727

Rodney Square, 1000 North King Street

Plaintiff

Allergan USA, Inc. Operating Company

Represented By

13 Attorneys Listed

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Anthony David Raucci

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9392

1201 North Market Street, P.O. Box 1347

Mena J. Gaballah

Email: menagaballah@paulhastings.com

Melanie R. Rupert

Email: melanierupert@paulhastings.com

Krystina L. Ho

Email: krystinaho@paulhastings.com

Eric W. Dittmann

Email: ericdittmann@paulhastings.com

Chad J. Peterman

Email: chadpeterman@paulhastings.com

Carl J. Minniti , III

Email: carlminniti@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Ashley N. Mays-Williams

Email: ashleymayswilliams@paulhastings.com

Amanda E. Hoffman

Email: amandahoffman@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Allergan, Inc. Operating Company

Represented By

16 Attorneys Listed

Vladimir J. Semendyai

Email: vladimirsemendyai@paulhastings.com

Karthik R. Kasaraneni

Email: karthikkasaraneni@paulhastings.com

David Valente

Email: davidvalente@paulhastings.com

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Anthony David Raucci

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9392

1201 North Market Street, P.O. Box 1347

Mena J. Gaballah

Email: menagaballah@paulhastings.com

Melanie R. Rupert

Email: melanierupert@paulhastings.com

Krystina L. Ho

Email: krystinaho@paulhastings.com

Eric W. Dittmann

Email: ericdittmann@paulhastings.com

Chad J. Peterman

Email: chadpeterman@paulhastings.com

Carl J. Minniti , III

Email: carlminniti@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Ashley N. Mays-Williams

Email: ashleymayswilliams@paulhastings.com

Amanda E. Hoffman

Email: amandahoffman@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Defendant

Allergan Pharmaceuticals Ireland Unlimited Company NPE (University / Research)

Represented By

13 Attorneys Listed

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Anthony David Raucci

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9392

1201 North Market Street, P.O. Box 1347

Mena J. Gaballah

Email: menagaballah@paulhastings.com

Melanie R. Rupert

Email: melanierupert@paulhastings.com

Krystina L. Ho

Email: krystinaho@paulhastings.com

Eric W. Dittmann

Email: ericdittmann@paulhastings.com

Chad J. Peterman

Email: chadpeterman@paulhastings.com

Carl J. Minniti , III

Email: carlminniti@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Ashley N. Mays-Williams

Email: ashleymayswilliams@paulhastings.com

Amanda E. Hoffman

Email: amandahoffman@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): 🇨🇦 Canada 🇪🇺 Europe 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

9 Patents

There are 9 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7332567
Fret protease assays for clostridial toxins
Filed: 2001-08-28
Issued: 2008-02-19
Expired (Term Ended) +311d PTA
Expires: 2022-07-05
US7354740
Animal product free system and process for purifying a botulinum toxin
Filed: 2005-03-03
Issued: 2008-04-08
Expired (Term Ended)
Expires: 2023-12-19
US8409828
Animal product free system and process for purifying a botulinum toxin
Filed: 2008-04-07
Issued: 2013-04-02
Active (0.6 yrs remaining)
Expires: 2027-06-16
US11033625
Method for stabilizing a toxin
Filed: 2020-10-15
Issued: 2021-06-15
Active (13.9 yrs remaining)
Expires: 2040-10-15
US11124786
Process and system for obtaining botulinum neurotoxin
Filed: 2019-11-04
Issued: 2021-09-21
Active (13.0 yrs remaining)
Expires: 2039-11-04

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+311 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

196

Dispositive

42

Granted

7

Denied

3

Pending / Review

137

Motions by Category

Procedural / Extension Motion 106 Motion to Dismiss 27 Claim Construction / Markman Filing 40 Motion to Compel Discovery 4 Motion to Strike / Sanctions 4 Motion for Summary Judgment (Rule 56) 15

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER: Defendants' Partial Motion to Dismiss Plaintiffs Allergan Pharmaceuticals Ireland Unlimited Company and Allergan USA, Inc. (D.I. 437 ) is GRANTED. Signed...
Entry #559 • 2025-05-30 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
NOTICE of Subsequent Authority Concerning Pending Motion for Summary Judgment (D.I. 344 ), by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, ...
Entry #557 • 2025-05-19 Document →
Motion to Dismiss Pending / Under Review
[SEALED] Supplemental Reply Brief re 437 PARTIAL Motion to Dismiss, filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Gaza, Anne) Modified on 4/7/20...
Entry #551 • 2025-04-07 Document →
Motion to Dismiss Pending / Under Review
[SEALED] Supplemental Answering Brief in Opposition re 437 PARTIAL Motion to Dismiss, filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA,...
Entry #550 • 2025-04-03 Document →
Motion to Dismiss Pending / Under Review
[SEALED] Supplemental Brief in Support of Partial Motion to Dismiss Plaintiffs Allergan Pharmaceuticals Ireland Company and Allergan USA, Inc., by Ajinomoto Alt...
Entry #548 • 2025-03-24 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
ORAL ORDER: The Court has reviewed D.I. 542 . Revance may depose Mr. Mulders for up to two hours. The proposed schedule at D.I. 542 page 6 is adopted, with the ...
Entry #544 • 2025-03-17 Document →

Docket Entries

(1117 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3712877.) - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland. (Attachments: # 1 Exhibit 1-26, # 2 Civil Cover Sheet)(twk) (Entered: 10/04/2021)

Entry #1 • 2021-10-01
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3712877.) - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland. (Attachments: # 1 Exhibit 1-26, # 2 Civil Cover Sheet)(twk) (Entered: 10/04/2021)

Entry #1 • 2021-10-01
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3712877.) - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland. (Attachments: # 1 Exhibit 1-26, # 2 Civil Cover Sheet)(twk) (Entered: 10/04/2021)

Entry #1 • 2021-10-01
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 10/04/2021)

Entry #2 • 2021-10-01
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,332,567 B2; 7,354,740 B2; 8,409,828 B2; 11,033,625 B2; 11,124,786 B2. (twk) (Entered: 10/04/2021)

Entry #3 • 2021-10-01
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc